NOS2 and neoplasm: Peripherally, the hormone reverses the arginase-1–dominant metabolism of tumour-associated macrophages, reinstating iNOS activity and nitric-oxide production that favour cytotoxic immunity over wound-healing fibrosis (8, 29, 30).